beta-lapachone has been researched along with Bone Diseases in 1 studies
beta-lapachone: antineoplastic inhibitor of reverse transcriptase, DNA topoisomerase, and DNA polymerase
beta-lapachone : A benzochromenone that is 3,4-dihydro-2H-benzo[h]chromene-5,6-dione substituted by geminal methyl groups at position 2. Isolated from Tabebuia avellanedae, it exhibits antineoplastic and anti-inflammatory activities.
Bone Diseases: Diseases of BONES.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gu, DR | 1 |
| Lee, JN | 1 |
| Oh, GS | 1 |
| Kim, HJ | 1 |
| Kim, MS | 1 |
| Lee, SH | 1 |
1 other study available for beta-lapachone and Bone Diseases
| Article | Year |
|---|---|
The inhibitory effect of beta-lapachone on RANKL-induced osteoclastogenesis.
Topics: AMP-Activated Protein Kinases; Animals; Bone Diseases; Cell Differentiation; Cell Survival; Gene Exp | 2017 |